Profilo di UNITED CUTE UNICORNSProfilo di Katya Tsygankova

Pitch deck | Pharma & Healthcare

Più proprietari
•
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
hiv investment presentation investor medicine pitch deck presentation red
Pitch deck | Pharma & Healthcare
Pubblicato:
Profilo di UNITED CUTE UNICORNSProfilo di Katya Tsygankova
Più proprietari

Proprietari

Profilo di UNITED CUTE UNICORNS
London, United Kingdom
Profilo di Katya Tsygankova
London, United Kingdom

Progetto creato per

profilo dell'utente
UCU design

Pitch deck | Pharma & Healthcare

The Israeli startup. KILLEVIR’s molecular biologists 
introduce unique anti-HIV mono-therapy drug, 
based on by Fullerene-poly-aminocaproic acid. Leggi di più

Pubblicato:

Strumenti

Campi creativi